Tag: james leverenz

18-NEU-687 Yan-650×450

Reversal of Alzheimer’s in Mouse Model Boosts BACE1 Inhibitors’ Prospects in Humans

Most substantial reversal of amyloid deposition in an animal study to date

18-NEU-509-Nakamura-Volumetric-MRI-650×450

Making the Most of Brain Imaging Through Quantitative Volumetric Analysis

Applications in MS, neurodegenerative disease and epilepsy

ADUpdate image
December 12, 2017/Geriatrics/Research

The Latest Insights in Treating Alzheimer’s Disease

Treating symptoms before they gain momentum; 50,000 patients needed for clinical trials

17-NEU-903-Leverenz-650×450
October 2, 2017/Geriatrics

New Research Consortium Gives Dementia with Lewy Bodies Its Due

Cleveland Clinic leads effort to emulate models for Alzheimer’s and Parkinson’s

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

16-neu-1982
October 25, 2016/Geriatrics

Aducanumab for Alzheimer’s: Putting PRIME in Perspective (Video)

A brain health expert looks ahead to phase 3 testing

Innovations-CQD-690×380

Getting an Earlier Start to Preserve Brain Health

Biomarkers and big data will help guide earlier interventions

Biobank-690×380
January 28, 2015/Neurosciences/Research

New Cleveland Clinic Biorepository Will Accelerate Brain Health Research

Collection at Lou Ruvo Center for Brain Health makes critical biospecimens available for collaborative work

BackPage 1 of 1Next
Advertisement
Ad